Literature DB >> 26417345

Integrated spatiotemporal-metabolic modelling bridges the gap between metabolism on the cellular level and organ function.

Agata Widera1.   

Abstract

Entities:  

Year:  2014        PMID: 26417345      PMCID: PMC4464484     

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


× No keyword cloud information.

Recently, Schliess et al. (2014[30]) have introduced a novel concept of spatiotemporal modelling. This work is of general interest, because it offers a possibility to bridge the level of metabolic functions at the subcellular level to tissue architecture and organ function. The authors used an already established spatiotemporal model of a liver lobule (Hoehme et al., 2010[17]; 2007[18]). This model simulates the position and coordinated movement of all hepatocytes in a representative lobule during the destruction and regeneration process after intoxication with hepatotoxic compounds. Moreover, it contains the microvessel of the liver lobule that allows simulation of perfusion and dry transport. The authors used this model to additionally integrate metabolic process into the simulated hepatocytes (Schliess et al., 2014[30]). Metabolic pathways of ammonia metabolism, the urea cycle in periportal and glutamine synthetase in the pericentral comportment of the liver lobule, were modelled as differential equations and integrated into the hepatocytes of the spatiotemporal model. The resulting integrated model allows the simulation of ammonia and its metabolites in the liver vein (the ‘liver outflow’) for a given concentration in the portal vein (the ‘liver inflow’). Moreover, the model predicts to which degree a certain extent or pattern of liver tissue destruction will compromise ammonia detoxification. This novel technique of integrated spatiotemporal tissue modelling may have a major impact on studies of organ toxicity in future (Wierling, 2014[35]; Godoy et al., 2013[9]; Drasdo et al., 2014[3]; Hammad et al., 2014[14]). Currently, studies on hepatotoxicity are often performed in vivo in rodents (Nussler et al., 2014[28]; Zhang et al., 2013[36]; Ghallab, 2013[7]; Kanda et al., 2008[21]; Monteiro et al., 2013[26]; Köhle et al., 2008[23]; Jaeschke et al., 2012[20]; van Kesteren et al., 2013[33]; Hammad et al., 2013[15]; Hadi et al., 2013[13]; Lo et al., 2012[24]). On the other hand in vitro systems with hepatocytes represent a popular system to analyse molecular mechanisms (Messner et al., 2013[25]; Godoy et al., 2009[8], 2010[11],[10] ; Hengstler et al., 2009[16]; Klingmüller et al., 2006[22]; Schyschka et al., 2013[32]; Watzek et al., 2013[34]; Muguruma et al., 2008[27]; Grinberg et al., 2014[12]; Schaap et al., 2012[29]; Schug et al., 2013[31]; Doktorova et al., 2012[1],[2] ; Ilkavets, 2013[19]; Gagné et al., 2012[6]; Fraczek et al., 2013[5]; Fernandes et al., 2003[4]). Although cultivated hepatocytes represent a valuable tool to qualitatively study molecular mechanisms it still is difficult to extrapolate their impact at the organ level. The work of Schliess et al. (2014[30]) is a first step in establishing modelling techniques that bridge the levels of intra or even subcellular metabolic pathways to the functionality and metabolic performance of entire organs.
  34 in total

1.  Dissecting modes of action of non-genotoxic carcinogens in primary mouse hepatocytes.

Authors:  Mirjam M Schaap; Edwin P Zwart; Paul F K Wackers; Ilse Huijskens; Bob van de Water; Timo M Breit; Harry van Steeg; Martijs J Jonker; Mirjam Luijten
Journal:  Arch Toxicol       Date:  2012-06-19       Impact factor: 5.153

2.  Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration.

Authors:  Stefan Hoehme; Marc Brulport; Alexander Bauer; Essam Bedawy; Wiebke Schormann; Matthias Hermes; Verena Puppe; Rolf Gebhardt; Sebastian Zellmer; Michael Schwarz; Ernesto Bockamp; Tobias Timmel; Jan G Hengstler; Dirk Drasdo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-19       Impact factor: 11.205

3.  Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: a mouse model to analyse the liver-bone axis.

Authors:  Andreas K Nussler; Britt Wildemann; Thomas Freude; Christian Litzka; Petra Soldo; Helmut Friess; Seddik Hammad; Jan G Hengstler; Karl F Braun; Viviane Trak-Smayra; Patricio Godoy; Sabrina Ehnert
Journal:  Arch Toxicol       Date:  2014-01-01       Impact factor: 5.153

4.  Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration.

Authors:  Freimut Schliess; Stefan Hoehme; Sebastian G Henkel; Ahmed Ghallab; Dominik Driesch; Jan Böttger; Reinhard Guthke; Michael Pfaff; Jan G Hengstler; Rolf Gebhardt; Dieter Häussinger; Dirk Drasdo; Sebastian Zellmer
Journal:  Hepatology       Date:  2014-05-12       Impact factor: 17.425

Review 5.  Promotion of hepatocarcinogenesis in humans and animal models.

Authors:  Christoph Köhle; Michael Schwarz; Karl Walter Bock
Journal:  Arch Toxicol       Date:  2008-01-16       Impact factor: 5.153

6.  Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis.

Authors:  Patricio Godoy; Jan G Hengstler; Iryna Ilkavets; Christoph Meyer; Anastasia Bachmann; Alexandra Müller; Gregor Tuschl; Stefan O Mueller; Steven Dooley
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

7.  AMAP, the alleged non-toxic isomer of acetaminophen, is toxic in rat and human liver.

Authors:  Mackenzie Hadi; Sanja Dragovic; Rachel van Swelm; Bram Herpers; Bob van de Water; Frans G M Russel; Jan N M Commandeur; Geny M M Groothuis
Journal:  Arch Toxicol       Date:  2012-08-23       Impact factor: 5.153

8.  Reduction of arginase I activity and manganese levels in the liver during exposure of rats to methylmercury: a possible mechanism.

Authors:  Hironori Kanda; Daigo Sumi; Akiko Endo; Takashi Toyama; Cheng-Liang Chen; Makoto Kikushima; Yoshito Kumagai
Journal:  Arch Toxicol       Date:  2008-05-17       Impact factor: 5.153

9.  Rapeseed oil-rich diet alters hepatic mitochondrial membrane lipid composition and disrupts bioenergetics.

Authors:  João P Monteiro; Cláudia V Pereira; Ana M Silva; Elisabete Maciel; Inês Baldeiras; Francisco Peixoto; Maria R Domingues; Amália S Jurado; Paulo J Oliveira
Journal:  Arch Toxicol       Date:  2013-05-01       Impact factor: 5.153

10.  A dual function of the furanocoumarin chalepensin in inhibiting Cyp2a and inducing Cyp2b in mice: the protein stabilization and receptor-mediated activation.

Authors:  Wei-Sheng Lo; Yun-Ping Lim; Chien-Chih Chen; Chih-Chien Hsu; Pavel Souček; Chul-Ho Yun; Wen Xie; Yune-Fang Ueng
Journal:  Arch Toxicol       Date:  2012-07-12       Impact factor: 5.153

View more
  4 in total

1.  Systems Toxicology.

Authors:  Ahmed Ghallab
Journal:  EXCLI J       Date:  2015-12-22       Impact factor: 4.068

2.  Highlight report: Software for tissue analysis and reconstruction.

Authors:  Mohie A M Haridy; Yasser S El-Sayed
Journal:  EXCLI J       Date:  2015-09-23       Impact factor: 4.068

3.  Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling.

Authors:  Agata Widera
Journal:  EXCLI J       Date:  2015-09-01       Impact factor: 4.068

4.  Perspectives of tissues in silico.

Authors:  Seddik Hammad; Mosaab A Omar; Mohammed F Abdallah; Hassan Ahmed
Journal:  EXCLI J       Date:  2015-03-11       Impact factor: 4.068

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.